Adaptin Bio Stock Price, News & Analysis
Company Description
Adaptin Bio (OTC Link: APTN) is a publicly traded company.
On a trailing twelve-month basis, Adaptin Bio reported net income of -$5.2M and diluted earnings per share of $-0.66.
This page provides a comprehensive overview of APTN stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
Latest News
SEC Filings
Adaptin Bio has filed 3 recent SEC filings, including 1 Form 8-K, 1 Form 10-K, 1 Form NT 10-K. The most recent filing was submitted on April 6, 2026. SEC filings provide transparency into a company's financial condition, material events, and regulatory compliance. View all APTN SEC filings →
Financial Highlights
operating income reached -$5.4M, and net income was -$5.2M. Diluted earnings per share stood at $-0.66. The company generated -$4.8M in operating cash flow. With a current ratio of 0.29, short-term liquidity bears monitoring.